331 related articles for article (PubMed ID: 15537497)
1. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
Lal A; Veinot JP; Leenen FH
Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
Lal A; Veinot JP; Ganten D; Leenen FH
J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
[TBL] [Abstract][Full Text] [Related]
3. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade.
Huang BS; Ahmad M; Tan J; Leenen FH
J Mol Cell Cardiol; 2007 Oct; 43(4):479-86. PubMed ID: 17714732
[TBL] [Abstract][Full Text] [Related]
6. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
7. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction.
Zhang YL; Zhou SX; Lei J; Yuan GY; Wang JF
Chin Med J (Engl); 2008 Nov; 121(21):2192-6. PubMed ID: 19080183
[TBL] [Abstract][Full Text] [Related]
8. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
[TBL] [Abstract][Full Text] [Related]
9. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
Zhang YL; Zhou SX; Wang MH; Wang JF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
[TBL] [Abstract][Full Text] [Related]
10. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
12. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
13. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
[TBL] [Abstract][Full Text] [Related]
14. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
Wang S; Fei K; Xu YW; Wang LX; Chen YQ
Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
[TBL] [Abstract][Full Text] [Related]
15. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Soeki T; Kishimoto I; Okumura H; Tokudome T; Horio T; Mori K; Kangawa K
J Am Coll Cardiol; 2005 Feb; 45(4):608-16. PubMed ID: 15708711
[TBL] [Abstract][Full Text] [Related]
16. Effects of spironolactone alone and in addition to a β-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts.
Milliez P; Gomes S; Champ-Rigot L; Callebert J; Samuel JL; Delcayre C
J Cardiovasc Pharmacol; 2012 Sep; 60(3):315-21. PubMed ID: 22710814
[TBL] [Abstract][Full Text] [Related]
17. [Role of cardiac aldosterone in post-infarction ventricular remodeling in rats].
Silvestre JS; Heymes C; Oubénaïssa A; Robert V; Aupetit-Faisant B; Carayon A; Swynghedauw B; Delcayre C
Arch Mal Coeur Vaiss; 1999 Aug; 92(8):991-6. PubMed ID: 10486652
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
[TBL] [Abstract][Full Text] [Related]
19. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
Geng DF; Wu W; Jin DM; Wang JF; Wu YM
Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
